Achieve Life Sciences stock falls after pricing capital raise of $45M via securities offering
Source: SeekingAlpha
2025-06-27 03:11:17 ET
Achieve Life Sciences ( NASDAQ: ACHV ) has announced the pricing of an underwritten public offering of 15M shares of its common stock and accompanying common warrants to purchase up to 15M shares of common stock, for an expected gross proceeds to be approximately $45.0 million. ...
Read the full article on Seeking Alpha
For further details see:
Achieve Life Sciences stock falls after pricing capital raise of $45M via securities offering
Achieve Life Sciences Inc.
NASDAQ: ACHV
ACHV Trading
0.73% G/L:
$5.409 Last:
1,030,133 Volume:
$5.10 Open:
ACHV Latest News
May 19, 2026 02:15:00 pm
Achieve Life Sciences Presents Safety Data from 52 Weeks of Continuous Cytisinicline Treatment
May 12, 2026 07:05:00 am
Achieve Life Sciences Strengthens Board and Commercial Leadership with Three Senior Appointments from Team Previously at Verona Pharma
May 12, 2026 07:00:00 am
Achieve Life Sciences Reports First Quarter 2026 Financial Results and Provides Business Updates
ACHV Stock Data
$234,761,887
51,636,968
N/A
28
N/A
Biotechnology & Life Sciences
Healthcare
CA
Bothell
